J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, issue.5795, pp.1960-1964, 2006.
DOI : 10.1126/science.1129139

J. Eyles, A. Puaux, X. Wang, B. Toh, C. Prakash et al., Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma, Journal of Clinical Investigation, vol.120, issue.6, pp.2030-2039, 2010.
DOI : 10.1172/JCI42002DS1

S. Rosenberg, J. Yang, R. Sherry, U. Kammula, M. Hughes et al., Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy, Clinical Cancer Research, vol.17, issue.13, pp.4550-4557, 2011.
DOI : 10.1158/1078-0432.CCR-11-0116

S. Grupp, M. Kalos, D. Barrett, R. Aplenc, D. Porter et al., Chimeric Antigen Receptor???Modified T Cells for Acute Lymphoid Leukemia, New England Journal of Medicine, vol.368, issue.16, pp.1509-1518, 2013.
DOI : 10.1056/NEJMoa1215134

N. Bercovici and A. Trautmann, Revisiting the role of T cells in tumor regression, OncoImmunology, vol.79, issue.3, pp.346-350, 2012.
DOI : 10.1002/ijc.24961

H. Cann, S. Van-netten, J. Van-netten, and C. , Dr William Coley and tumour regression: a place in history or in the future, Postgrad Med J, vol.79, pp.672-80, 2003.

A. Boissonnas, L. Fetler, I. Zeelenberg, S. Hugues, and S. Amigorena, In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor, The Journal of Experimental Medicine, vol.115, issue.2, pp.345-356, 2007.
DOI : 10.1084/jem.20041378

B. Breart, F. Lemaitre, S. Celli, and P. Bousso, Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice, Journal of Clinical Investigation, vol.118, issue.4, pp.1390-1397, 2008.
DOI : 10.1172/JCI34388

J. Hollenbaugh, J. Reome, M. Dobrzanski, and R. Dutton, The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis, The Journal of Immunology, vol.173, issue.3, pp.1738-1781, 2004.
DOI : 10.4049/jimmunol.173.3.1738

A. Prevost-blondel, M. Neuenhahn, M. Rawiel, and H. Pircher, Differential requirement of perforin and IFN-?? in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen, European Journal of Immunology, vol.30, issue.9, pp.2507-2522, 2000.
DOI : 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V

H. Salmon, K. Franciszkiewicz, D. Damotte, M. Dieu-nosjean, P. Validire et al., Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors, Journal of Clinical Investigation, vol.122, issue.3, pp.899-910, 2012.
DOI : 10.1172/JCI45817DS1

P. Mrass, H. Takano, L. Ng, S. Daxini, M. Lasaro et al., Random migration precedes stable target cell interactions of tumor-infiltrating T cells, The Journal of Experimental Medicine, vol.70, issue.12, pp.2749-2761, 2006.
DOI : 10.3109/10739689609148303

A. Boissonnas, F. Licata, L. Poupel, J. S. Fetler, L. Krumeich et al., CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network, Neoplasia, vol.15, issue.1, p.85, 2013.
DOI : 10.1593/neo.121572

J. Engelhardt, B. Boldajipour, P. Beemiller, P. Pandurangi, C. Sorensen et al., Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells, Cancer Cell, vol.21, issue.3, pp.402-417, 2012.
DOI : 10.1016/j.ccr.2012.01.008

B. Vingert, O. Adotevi, D. Patin, S. Jung, P. Shrikant et al., The Shiga toxin B-subunit targets antigenin vivo to dendritic cells and elicits anti-tumor immunity, European Journal of Immunology, vol.145, issue.5, pp.1124-1135, 2006.
DOI : 10.1002/eji.200535443

F. Asperti-boursin, E. Real, G. Bismuth, A. Trautmann, and E. Donnadieu, CCR7 ligands control basal T cell motility within lymph node slices in a phosphoinositide 3???kinase??? independent manner, The Journal of Experimental Medicine, vol.159, issue.5, pp.1167-1179, 2007.
DOI : 10.4049/jimmunol.173.1.50

D. Denardo, D. Brennan, E. Rexhepaj, B. Ruffell, S. Shiao et al., Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy, Cancer Discovery, vol.1, issue.1, pp.54-67, 2011.
DOI : 10.1158/2159-8274.CD-10-0028

X. Yang, P. Lu, Y. Ishida, W. Kuziel, C. Fujii et al., Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization, International Journal of Cancer, vol.13, issue.2, pp.335-345, 2006.
DOI : 10.1002/ijc.21371

J. Xue, S. Schmidt, J. Sander, A. Draffehn, W. Krebs et al., Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation, Immunity, vol.40, issue.2, pp.274-288, 2014.
DOI : 10.1016/j.immuni.2014.01.006

E. Lin, A. Nguyen, R. Russell, and J. Pollard, Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy, The Journal of Experimental Medicine, vol.112, issue.6, p.727, 2001.
DOI : 10.1038/sj.onc.1201869

J. Pollard, Trophic macrophages in development and disease, Nature Reviews Immunology, vol.87, issue.4, pp.259-270, 2009.
DOI : 10.1038/nri2528

H. Shime, M. Matsumoto, H. Oshiumi, S. Tanaka, A. Nakane et al., Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors, Proc. Natl. Acad. Sci, pp.2066-2071, 2012.
DOI : 10.1073/pnas.1113099109

F. Klug, H. Prakash, P. Huber, T. Seibel, N. Bender et al., Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy, Cancer Cell, vol.24, issue.5, pp.589-602, 2013.
DOI : 10.1016/j.ccr.2013.09.014

G. Beatty, E. Chiorean, M. Fishman, B. Saboury, U. Teitelbaum et al., CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans, CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans, pp.1612-1616, 2011.
DOI : 10.1126/science.1198443

I. Buhtoiarov, P. Sondel, J. Wigginton, T. Buhtoiarova, E. Yanke et al., Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages, Immunology, vol.181, issue.2, pp.226-239, 2011.
DOI : 10.1111/j.1365-2567.2010.03357.x

O. Haabeth, K. Lorvik, C. Hammarström, I. Donaldson, G. Haraldsen et al., Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer, Nature Communications, vol.65, p.240, 2011.
DOI : 10.1093/jnci/80.17.1393

V. Miguel, R. Cherpes, T. Watson, L. Mckenna, and K. , CTL Induction of Tumoricidal Nitric Oxide Production by Intratumoral Macrophages Is Critical for Tumor Elimination, The Journal of Immunology, vol.185, issue.11, pp.6706-6718, 1950.
DOI : 10.4049/jimmunol.0903411

M. Chmielewski, C. Kopecky, A. Hombach, and H. Abken, IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression, Cancer Research, vol.71, issue.17, pp.5697-5706, 2011.
DOI : 10.1158/0008-5472.CAN-11-0103

C. Bogdan, J. Mattner, and U. Schleicher, The role of type I interferons in non-viral infections, Immunological Reviews, vol.52, issue.1, pp.33-48, 2004.
DOI : 10.1038/nm0897-849

S. Perez-gracia, J. Rouzaut, A. Sanmamed, M. , L. Bon et al., Direct effects of type I interferons on cells of the immune system, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.17, pp.2619-2627, 2011.

A. Sistigu, T. Yamazaki, E. Vacchelli, K. Chaba, D. Enot et al., Cancer cell???autonomous contribution of type I interferon signaling to the efficacy of chemotherapy, Nature Medicine, vol.8, issue.11, pp.1301-1309, 2014.
DOI : 10.1038/nm.3708

M. Heusinkveld and S. Van-der-burg, Identification and manipulation of tumor associated macrophages in human cancers, Journal of Translational Medicine, vol.9, issue.1, p.216, 2011.
DOI : 10.1186/1479-5876-9-216

J. Hollenbaugh and R. Dutton, IFN-?? Regulates Donor CD8 T Cell Expansion, Migration, and Leads to Apoptosis of Cells of a Solid Tumor, The Journal of Immunology, vol.177, issue.5, pp.3004-3011, 2006.
DOI : 10.4049/jimmunol.177.5.3004

A. Textor, J. Listopad, L. Wührmann, C. Perez, A. Kruschinski et al., Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN??, Cancer Research, vol.74, issue.23, pp.6796-6805, 2014.
DOI : 10.1158/0008-5472.CAN-14-0079

O. Adotevi, B. Vingert, L. Freyburger, P. Shrikant, Y. Lone et al., B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity, J. Immunol. Baltim. Md, vol.179, pp.3371-3379, 1950.
URL : https://hal.archives-ouvertes.fr/hal-00172517

F. Sandoval, M. Terme, M. Nizard, C. Badoual, M. Bureau et al., Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors, Science Translational Medicine, vol.5, issue.172, pp.172-192, 2013.
DOI : 10.1126/scitranslmed.3004888

H. Lee, H. Choi, S. Ha, K. Lee, and Y. Kwon, Recruitment of monocytes/macrophages in different tumor microenvironments, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1835, issue.2, pp.170-179, 2013.
DOI : 10.1016/j.bbcan.2012.12.007

M. Egeblad, A. Ewald, H. Askautrud, M. Truitt, B. Welm et al., Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy, Disease Models and Mechanisms, vol.1, issue.2-3, pp.155-167, 2008.
DOI : 10.1242/dmm.000596

B. Qian, J. Li, H. Zhang, T. Kitamura, J. Zhang et al., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, Nature, vol.64, issue.7355, pp.222-225, 2011.
DOI : 10.1038/nature10138

N. Serbina, T. Salazar-mather, C. Biron, W. Kuziel, and E. Pamer, TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection, Immunity, vol.19, issue.1, pp.59-70, 2003.
DOI : 10.1016/S1074-7613(03)00171-7

Y. Ma, S. Mattarollo, S. Adjemian, H. Yang, L. Aymeric et al., CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy, Cancer Research, vol.74, issue.2, pp.436-445, 2014.
DOI : 10.1158/0008-5472.CAN-13-1265

H. Lum, I. Buhtoiarov, B. Schmidt, G. Berke, D. Paulnock et al., Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha, Immunology, vol.174, issue.2, pp.261-270, 2006.
DOI : 10.1007/s00262-003-0443-2

A. Pommier, A. Audemard, A. Durand, R. Lengagne, A. Delpoux et al., Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells, Proc. Natl. Acad. Sci, pp.13085-13090, 2013.
DOI : 10.1073/pnas.1300314110

S. Mok, R. Koya, C. Tsui, J. Xu, L. Robert et al., Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy, Cancer Research, vol.74, issue.1, pp.153-161, 2014.
DOI : 10.1158/0008-5472.CAN-13-1816

M. Sluijter, T. Van-der-sluis, P. Van-der-velden, M. Versluis, B. West et al., Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy, PLoS ONE, vol.8, issue.8, p.104230, 2014.
DOI : 10.1371/journal.pone.0104230.g005

L. Bon, A. Etchart, N. Rossmann, C. Ashton, M. Hou et al., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon, Nature Immunology, vol.4, issue.10, pp.1009-1015, 2003.
DOI : 10.1038/ni978

W. Kastenmüller, M. Brandes, Z. Wang, J. Herz, J. Egen et al., Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8+ T Cell Responses in the Lymph Node, Immunity, vol.38, issue.3, pp.502-513, 2013.
DOI : 10.1016/j.immuni.2012.11.012

S. Wang, S. Fouquet, M. Chapon, H. Salmon, F. Regnier et al., Early T Cell Signalling Is Reversibly Altered in PD-1+ T Lymphocytes Infiltrating Human Tumors, PLoS ONE, vol.204, issue.3, p.17621, 2011.
DOI : 10.1371/journal.pone.0017621.s006